Joinn Laboratories(China)Co.,Ltd. (HKG:6127)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
23.00
-0.60 (-2.54%)
Apr 29, 2026, 10:34 AM HKT
130.00%
Market Cap 31.29B
Revenue (ttm) 1.84B
Net Income (ttm) 331.44M
Shares Out n/a
EPS (ttm) 0.45
PE Ratio 94.40
Forward PE 878.66
Dividend 0.00 (0.01%)
Ex-Dividend Date Jun 26, 2025
Volume 1,436,934
Average Volume 6,308,739
Open 23.92
Previous Close 23.60
Day's Range 22.54 - 23.92
52-Week Range 9.36 - 28.70
Beta 0.92
RSI 62.48
Earnings Date Mar 30, 2026

About HKG:6127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. Its Clinical Trial and Related Services segment provide clinical contract research organization s... [Read more]

Sector Healthcare
Founded 1995
Employees 2,649
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6127
Full Company Profile

Financial Performance

In 2025, HKG:6127's revenue was 1.66 billion, a decrease of -17.87% compared to the previous year's 2.02 billion. Earnings were 297.84 million, an increase of 302.08%.

Financial numbers in CNY

News

There is no news available yet.